Recent data from the National Inpatient Sample (NIS) has unveiled a concerning trend in the American West – a significant surge in cardiomyopathy-associated hospital admissions among methamphetamine users. According to a study conducted by Mohammad Bhuiyan, PhD, and colleagues from Louisiana State University Health Sciences Center at Shreveport, methamphetamine-related cardiomyopathy admissions skyrocketed by 231% from
Health
Space flight has long been associated with a range of physical challenges for astronauts, with a recent study shedding light on a particularly concerning issue – headaches. According to a prospective study conducted by Dr. Willebrordus P. J. van Oosterhout and his team at Leiden University Medical Center, 91.7% of astronauts who participated in long-haul
The study conducted by Zheng Chang, PhD, and colleagues at the Karolinska Institute in Stockholm, Sweden, aimed to investigate the relationship between starting medication for attention-deficit/hyperactivity disorder (ADHD) and the risk of mortality among patients with ADHD. The research revealed interesting findings that highlighted the potential benefits of medication initiation in reducing the risk of
In the ongoing battle for health care coverage, one of the most pressing issues is the increasing difficulty faced by patients in obtaining coverage for home ventilators. Amyotrophic lateral sclerosis (ALS) patients, in particular, are finding it increasingly challenging to acquire the necessary equipment to assist with their breathing as the condition progresses. The costs
Richard Lowenthal, president and CEO of ARS Pharmaceuticals, highlighted the importance of testing intranasal epinephrine spray ARS-1 (also known as neffy) under extreme temperatures, citing concerns from parents about leaving EpiPens in hot cars. This testing sheds light on the need for medical interventions to withstand various environmental conditions for optimal effectiveness. Landon Myer, MD,
UnitedHealth Group (UHG) has reported unprecedented financial success, with $22.4 billion in profits and a revenue of $371.6 billion in 2023. Through vertical integration, UHG has created a value-chain monopoly that encompasses health insurance, medical services, healthcare data, and pharmaceuticals. While impressive from a financial standpoint, this model raises concerns about its impact on the
A recent observational cohort study conducted within the U.K. Biobank revealed an alarming association between childhood amblyopia, commonly referred to as “lazy eye,” and an increased risk of developing cardiometabolic disorders in adulthood. The researchers, led by ophthalmic epidemiologist Jugnoo Rahi of University College London, found that individuals over 40 years old with a history
Tuberculosis (TB) remains a significant global health concern, affecting individuals both with and without HIV. The standard treatment regimens for TB often involve the use of isoniazid, but the drug can sometimes lead to serious adverse effects and tolerability issues. In a recent phase II randomized controlled trial, a novel fixed-dose combination of alpibectir-ethionamide has
The study conducted by Elan Louis, MD, and his team at the University of Texas Southwestern Medical Center in Dallas revealed some shocking statistics. Over a period of 5 years, they found that the cumulative prevalence of dementia in people with essential tremor was 18.5%. Additionally, the average annual conversion rate of mild cognitive impairment
The integration of artificial intelligence (AI) in healthcare settings to listen to clinician-patient conversations and process information raises significant concerns regarding security and privacy. As Forbes reports, while the potential benefits of ambient AI are apparent, the unclear stance on how data is being handled and protected poses a major risk to patient confidentiality. Government